ARCHIVES

DCT Board Approves Phase 2/3 Studies Of LAK-IL-2

This article is from The Cancer Letter archive.

Vol. 12 No. 07 | February 14, 1986

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group, Cancer Center Trials Listed

July 27, 2007

FDA Approves HPV Test

April 25, 2003

Breast Cancer Action Claims “Victory On Avastin.”

December 14, 2007

NCI Advisory Group, Other Cancer Meeting

May 26, 1978

Palbocicilib Doubles PFS In Phase II Trial to 20.2 Months

April 25, 2014

GAO Suggests No Limit On Indirect Costs But Ceiling On Total Costs

September 7, 1979